Revolutionizing Medicine Through Car T-Cell Immunotherapies

  • Discussing the uniqueness of cell therapies
  • Understanding the complexities of developing commercial cell and gene therapy products:
    • Manufacturing: What does the process look like?
    • Quality: Best practices for quality tests and comparability studies
    • Supply chain: Exploring the uniqueness of the supply chain and strategies
  • Navigating the regulatory pathway of the FDA or other agencies
  • Examining next generation technologies to meet market needs
  • Looking forward: Assessing trends and drivers for both personalized and broadly applicable cell-based medicines

Leave a reply

Please enter your comment!
Please enter your name here